Dr. Arteaga joined Vanderbilt University in 1989 where he now holds the Donna S. Hall Chair in Breast Cancer Research and serves as Professor of Medicine and Cancer Biology. He is Director of the Center for Cancer Targeted Therapies and the Breast Cancer Program of the Vanderbilt-Ingram Cancer Center (VICC) where he also serves as Associate Director for Translational/Clinical Research. He has over 300 publications in the areas of signaling by growth factor receptors and oncogenes in breast tumor cells, development of targeted therapies and biomarkers of drug action and resistance, and investigator-initiated clinical trials in breast cancer.
He is a member of the American Society of Clinical Investigation (1998) and the Association of American Physicians (2005). Arteaga is the recipient of the 2003 AACR Richard & Hinda Rosenthal Award, a 2007-2017 ACS Clinical Research Professor Award, the 2009 Gianni Bonadonna Award from the American Society of Clinical Oncology (ASCO), the 2011 Brinker Award for Scientific Distinction from the Susan G. Komen for the Cure Foundation, and the 2015 Prize for Scientific Excellence in Medicine from the American-Italian Cancer Foundation. He was elected Fellow of the AACR Academy in 2015, and serves in the Scientific Advisory Board of the Komen Foundation. He has chaired the AACR Special Conference ‘Advances in Breast Cancer Research’ since 2003 and has served as AACR co-chair of the annual San Antonio Breast Cancer Symposium since 2009. In 2014, he served as President of the American Association for Cancer Research (AACR).